MYC and cancer: To map more precisely the location of the Myc hypomorphism bottleneck in progression of lung and pancreas pre-cancers, we constructed an allelic series of knock-in mice in which different levels of the reversibly switchable, 4-hydroxytamoxifen-dependent Myc variant MycERT2 may be ectopically activated at will in lung or pancreas epithelium47.